Spyryx Biosciences (Series A)

Funding Details
Awarder
Inbox
Date Award
May 07, 2015
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$18,000,000

Company Info
Company Description
Spyryx Biosciences develops a next-generation therapeutics for obstructive lung diseases.
Market
Cystic Fibrosis
Location
Research Triangle Park, North Carolina, USA
Coinvestors
5AM Ventures, Canaan Partners, Hatteras Venture Partners

Links